GlassScriptPrepare for your visit
Gerard Sanacora
Psychiatry · New Haven, CT · NPI 1992779151
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$94,138.72
in general payments reported to CMS, 2019-2025 · $13K in 2025
The $13K reported for 2025 was more than what 96% of Psychiatry providers received nationally (typical 2025 total: $176).
Who reported paying
General payments only, top 6 by amount.
- Merck Sharp & Dohme LLC $20,034.03
- Sage Therapeutics, LLC $16,330.86
- Boehringer Ingelheim International Gmbh $10,344.05
- Abbvie INC. $7,772.89
- Janssen Scientific Affairs, LLC $7,767.43
- Boehringer Ingelheim Pharmaceuticals, INC. $7,338.88
Drugs and devices associated with these payments
Sotyktu Vraylar
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Gerard Sanacora listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/135795/gerard-sanacora